Policy & Medicine October 9, 2024
As healthcare costs soar, the Congressional Budget Office (CBO) has recently shed light on a hot political issue: the perceived high cost of prescription drugs in the United States. Their latest report, published in October 2024, meticulously analyzes various policy measures aimed at curbing these costs.
The Core Problem
Prescription drug pricing remains a critical political issue, impacting the financial well-being of millions. The CBO’s report underscores a complex interplay of market exclusivities, competition, and regulatory measures that set the stage for current drug prices. As detailed, these factors, including exclusive sales rights and insurance coverage, significantly insulate consumers from...
Today's Sponsors
Today's Sponsor